[Continous ambulatory peritoneal dialysis (CAPD)].
Eleven patients were treated with continuous ambulatory peritoneal dialysis (CAPD) for periods of 2-7 months (48 patient-months). Clinical and biochemical control of uremia was adequate in all patients. Control of hypertension and serum phosphate level was easier than with previous intermittent peritoneal dialysis (IPD). Mean protein loss during CAPD was 9.7 +/- 2.7 g/day. Seven episodes of peritonitis occurred in 3 patients (1 peritonitis/6.8 months). General use of CAPD cannot be recommended until the high incidence of peritonitis is reduced by urgently needed technical improvements. A potential complication of CAPD was that triglycerides were markedly elevated in 4 patients.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D005260:Female; D006801:Humans; D006973:Hypertension / Q000628:therapy; D007674:Kidney Diseases / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D010538:Peritonitis / Q000628:therapy; D010710:Phosphates / Q000097:blood; D014280:Triglycerides / Q000097:blood
D010710:Phosphates; D014280:Triglycerides
Kontinuierliche ambulante Pertonealdialyse (CAPD).